首页> 美国卫生研究院文献>The Oncologist >Efficacy of Prophylactic Treatment for Oxycodone‐Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized Placebo‐Controlled Double‐Blind Trial
【2h】

Efficacy of Prophylactic Treatment for Oxycodone‐Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized Placebo‐Controlled Double‐Blind Trial

机译:羟考酮对恶性肿瘤患者的呕吐和呕吐的预防性治疗功效:一项随机安慰剂对照双盲试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background.Although opioid‐induced nausea and vomiting (OINV) often result in analgesic undertreatment in patients with cancer, no randomized controlled trials have evaluated the efficacy of prophylactic antiemetics for preventing OINV. We conducted this randomized, placebo‐controlled, double‐blind trial to evaluate the efficacy and safety of prophylactic treatment with prochlorperazine for preventing OINV.
机译:背景:尽管阿片类药物引起的恶心和呕吐(OINV)通常会导致癌症患者的止痛药治疗不足,但尚无随机对照试验评估预防性止吐药预防OINV的功效。我们进行了这项随机,安慰剂对照,双盲试验,以评估用氯丙嗪预防OINV的预防性疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号